These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1685801)

  • 1. Clinical evaluation of tumor-associated trypsin inhibitor (TATI). Proceedings of a symposium. Barcelona, September 24, 1989.
    Scand J Clin Lab Invest Suppl; 1991; 207():1-73. PubMed ID: 1685801
    [No Abstract]   [Full Text] [Related]  

  • 2. Biochemistry and clinical role of trypsinogens and pancreatic secretory trypsin inhibitor.
    Paju A; Stenman UH
    Crit Rev Clin Lab Sci; 2006; 43(2):103-42. PubMed ID: 16517420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concentration of tumor-associated trypsin inhibitor (TATI) in pleural effusions.
    Klockars M; Pettersson T; Fröseth B; Selroos O; Stenman UH
    Chest; 1990 Nov; 98(5):1159-64. PubMed ID: 2225961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour-associated trypsin inhibitor (TATI) in ovarian cancer.
    Halila H; Lehtovirta P; Stenman UH
    Br J Cancer; 1988 Mar; 57(3):304-7. PubMed ID: 3162682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-associated trypsin inhibitor (TATI) in primary esophageal carcinoma.
    Gion M; Mione R; Tremolada C; Dalla Palma P; Ruol A; Dittadi R; Leon A; Nosadini A; Castoro C; Bruscagnin G
    Scand J Clin Lab Invest Suppl; 1991; 207():37-41. PubMed ID: 1780688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-associated trypsin inhibitor as a possible marker in male infertility.
    Banfi G; Murone M; Vigano P; Brigante C; Bonini PA
    Scand J Clin Lab Invest Suppl; 1991; 207():51-3. PubMed ID: 1780692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biology and function of tumor-associated trypsin inhibitor, TATI.
    Stenman UH; Koivunen E; Itkonen O
    Scand J Clin Lab Invest Suppl; 1991; 207():5-9. PubMed ID: 1780691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative evaluation of the ability of serum CA 125, CA 19-9, CA 15-3, CA 50, CA 72-4 and TATI assays in reflecting the course of disease in patients with ovarian carcinoma.
    Gadducci A; Ferdeghini M; Ceccarini T; Prontera C; Facchini V; Bianchi R; Fioretti P
    Eur J Gynaecol Oncol; 1990; 11(2):127-33. PubMed ID: 2379512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-associated trypsin inhibitor in induced and acquired immunodeficiency. Studies on transplanted and HIV-infected patients.
    Banfi G; Pirali A; Locatelli M; Murone M; Bonini PA
    Scand J Clin Lab Invest Suppl; 1991; 207():55-8. PubMed ID: 1780693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyst fluid tumor-associated trypsin inhibitor may be helpful in the differentiation of cystic pancreatic lesions.
    Räty S; Sand J; Alfthan H; Haglund C; Nordback I
    J Gastrointest Surg; 2004; 8(5):569-74. PubMed ID: 15239993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical evaluation of tumor-associated trypsin inhibitor (TATI) in benign and malignant gynecological tumor].
    Shigemasa K; Hiura M; Ioka A; Yokoyama T; Nogawa T; Chiba T
    Nihon Sanka Fujinka Gakkai Zasshi; 1993 Mar; 45(3):256-7. PubMed ID: 8492013
    [No Abstract]   [Full Text] [Related]  

  • 12. Tumour-associated trypsin inhibitor, TATI. Clinical use and biological function.
    Stenman UH; Koivunen E; Itkonen O; Turpeinen U; Halila H; Huhtala ML
    Ann Chir Gynaecol; 1989; 78(1):77-82. PubMed ID: 2667452
    [No Abstract]   [Full Text] [Related]  

  • 13. Editorial comment on: Increased expression of tumor-associated trypsin inhibitor, TATI, in prostate cancer and in androgen-independent 22Rv1 cells.
    Edwards J; Leung HY
    Eur Urol; 2007 Dec; 52(6):1680-1. PubMed ID: 17306442
    [No Abstract]   [Full Text] [Related]  

  • 14. Editorial comment on: Increased expression of tumor-associated trypsin inhibitor, TATI, in prostate cancer and in androgen-independent 22Rv1 cells.
    Schalken J
    Eur Urol; 2007 Dec; 52(6):1679. PubMed ID: 17306439
    [No Abstract]   [Full Text] [Related]  

  • 15. Tumor-associated trypsin inhibitor (TATI) in the diagnosis of lung cancer.
    Pecchio F; Rapellino M; Baldi S; Casali V; Libertucci D; Coni F
    Scand J Clin Lab Invest Suppl; 1991; 207():63-4. PubMed ID: 1780695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumour-associated trypsin inhibitor and tumour-associated trypsin.
    Stenman UH
    Scand J Clin Lab Invest Suppl; 1990; 201():93-101. PubMed ID: 2244188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased expression of tumor-associated trypsin inhibitor, TATI, in prostate cancer and in androgen-independent 22Rv1 cells.
    Paju A; Hotakainen K; Cao Y; Laurila T; Gadaleanu V; Hemminki A; Stenman UH; Bjartell A
    Eur Urol; 2007 Dec; 52(6):1670-9. PubMed ID: 17306443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-associated trypsin inhibitor (TATI) in bone diseases.
    Rapellino M; Pecchio F; Broggi S; Baldi C; Ricardi G; Libertucci D
    Scand J Clin Lab Invest Suppl; 1991; 207():65-6. PubMed ID: 1780696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Significance of the the tumor markers, Ca-125 and tumor-associated trypsin inhibitor in patients with carcinoma of the cervix and uterus].
    Ilić RS; Mihailović D
    Srp Arh Celok Lek; 1992; 120(3-4):97-9. PubMed ID: 1465666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Tissue polypeptide antigen and tumor trypsin inhibitor in pleural effusions of various etiologies].
    Plavec G; Lazarov A; Odavić M; Dangubić V; Ninković M
    Vojnosanit Pregl; 1992; 49(4):325-9. PubMed ID: 1481445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.